GIP and GLP1 medications are designed to help with blood sugar management in people with type 2 diabetes. They are a type drug called a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist and is the first medication in the GIP/GLP-1 receptor agonist drug class, per the FDA.
